Back to Search Start Over

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103).

Source :
AIDS Weekly; 3/3/2025, p41-41, 1p
Publication Year :
2025

Details

Language :
English
ISSN :
15324524
Database :
Complementary Index
Journal :
AIDS Weekly
Publication Type :
Periodical
Accession number :
183317461